Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIPEXI: NT 201 in Pediatric Sialorrhea
NCT02270736Phase 3Completed
- Sponsor
- Merz
- Start
- Feb 2015
- Primary completion
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 3 trial of incobotulinumtoxinA in sialorrhea, sponsored by Merz. Started Feb 2015; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
sialorrhea
Beyond the preview
Go deeper on NCT02270736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02270736.